Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Misinformation and outdated beliefs about screening tests, treatment options, and effects on sexual health continue to cloud understanding about this disease.
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Columbia bioengineers are the first to program bacteria that guide immune cells to tumors, which could make more cancers treatable with immunotherapies.
The association between neighborhood walkability and obesity-related cancers was stronger among women living in neighborhoods with higher levels of poverty.
Physician-scientist Neil Vasan brings the perspectives he's gained from classical singing and structural biology to his search for new breast cancer treatments.
Biomedical engineer Santiago Correa uses his expertise in nanotechnology to create injectable biomaterials that reprogram the body’s immune system to fight cancer, autoimmune disease, and infection.
When all evidence of cancer disappeared from Catherine Spina’s patient after radiation of a single metastasis, she became convinced that radiotherapy may be key to a new treatment approach.